| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |